Name (Synonyms) | Correlation | |
---|---|---|
D004417 | Dyspnea NIH | 0.58 |
D011024 | Pneumonia, Viral NIH | 0.17 |
D003141 | Communicable Diseases NIH | 0.12 |
D011014 | Pneumonia NIH | 0.08 |
D007239 | Infection NIH | 0.08 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.07 |
D018352 | Coronavirus Infections NIH | 0.06 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0002098 | Respiratory distress HPO | 0.71 |
HP:0002090 | Pneumonia HPO | 0.15 |
There is one clinical trial.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently spreading rapidly around the globe, causing a major public health issue. There is currently very few data about the impact of COVID-19 on pregnancy, and potential in utero infection. This is a prospective observational study of COVID-19 diagnosed pregnant patients. This objective is to examine the impact of COVID-19 during pregnancy on the rates of obstetric and perinatal complications.
Description: To compare the complications rates of pregnant women tested positive for the SARS-CoV-2 (study group), with reference rates in a Covid-free population.
Measure: examine the impact of COVID-19 during pregnancy Time: 12 monthsDescription: To record clinical presentation of pregnant participants with COVID-19
Measure: Clinical presentation Time: 12 months